Welcome to our dedicated page for Zurn Elkay Water Solutions SEC filings (Ticker: ZWS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Zurn Elkay Water Solutions Corporation (NYSE: ZWS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Zurn Elkay’s common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades on the New York Stock Exchange under the symbol ZWS, so its filings offer detailed insight into its water management business.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q to understand Zurn Elkay’s financial condition, risk factors and discussion of operations. These core filings complement the company’s description as a growth-oriented, pure-play water management business with a specification-driven portfolio of water safety and control products, flow systems products, hygienic and environmental products and filtered drinking water products.
The company also files current reports on Form 8-K to furnish earnings releases and other material events. Recent 8-K filings have been used to provide quarterly financial results for specific periods, including net sales, income from operations and adjusted EBITDA, along with management commentary. These filings help investors track short-term performance and any significant developments that Zurn Elkay chooses to disclose between periodic reports.
On this page, Stock Titan surfaces Zurn Elkay’s SEC filings in real time as they appear on EDGAR and enhances them with AI-powered summaries. These summaries are intended to highlight key points in lengthy documents, such as major changes in financial metrics, updates on the company’s water management portfolio, or notable risk disclosures, without replacing the full text of the filings.
Users can also access insider transaction reports on Form 4, proxy statements on Schedule 14A and other relevant forms as they become available. Together, these filings provide a structured view of Zurn Elkay Water Solutions’ regulatory reporting, supporting deeper analysis of the company’s governance, compensation disclosures and capital markets activity.
Zurn Elkay Water Solutions Corp director Peggy Troy reported receiving an award of 2,900 shares of common stock on February 10, 2026. The grant is structured as restricted stock units that vested immediately, increasing her directly held stake to 64,517 shares. Although vested, the units will not be paid out in shares until six months after she ceases serving as a director.
Zurn Elkay Water Solutions Corp director equity grant: Director Mark S. Bartlett reported receiving 2,900 shares of common stock on February 10, 2026, coded as an acquisition. The award came through a restricted stock unit grant that vested immediately.
After this grant, Bartlett beneficially owns 141,583 shares of Zurn Elkay Water Solutions common stock in direct ownership. Although the restricted stock units vested right away, they will not be paid out until six months after he ceases serving as a director.
Zurn Elkay Water Solutions director Rosemary Schooler reported an award of 2,900 shares of common stock on February 10, 2026, coded as an acquisition at no purchase price. The footnote explains this is a restricted stock unit grant that vested immediately.
After this grant, Schooler beneficially owns 61,244 shares directly. Although the units vest right away, they are not actually paid out in shares until six months after she ceases serving as a director, so the economic benefit is deferred until her board service ends.
Zurn Elkay Water Solutions Corp director Timothy J. Jahnke reported receiving 2,900 shares of common stock on February 10, 2026 through a restricted stock unit grant. The units vested immediately but will not be paid out until six months after he stops serving as a director.
After this grant, Jahnke beneficially owns 291,864 shares directly and 162,000 shares indirectly through an irrevocable trust. The filing reflects an equity-based compensation award rather than an open‑market stock purchase.
Zurn Elkay Water Solutions director Thomas Christopoul reported receiving 2,900 shares of common stock on February 10, 2026 through a restricted stock unit grant. The award vested immediately but will not be paid out until six months after he stops serving as a director.
After this transaction, Christopoul beneficially owns 117,171 shares of Zurn Elkay common stock, held directly.
Zurn Elkay Water Solutions director David C. Longren received 2,900 shares of common stock on a restricted stock unit grant dated February 10, 2026. The grant vested immediately but will not be paid out until six months after he stops serving as a director. Following this award, he beneficially owns 97,610 shares of Zurn Elkay common stock in direct ownership.
Zurn Elkay Water Solutions Chief Information Officer Michael Troutman reported stock transactions related to performance-based awards. On February 6, 2026, he acquired 17,881 shares of common stock at no cost upon vesting of performance stock units covering the period from January 1, 2023 to December 31, 2025, including dividend equivalents.
On February 10, 2026, 5,922 shares were sold at a weighted average price of $51.8 per share to cover tax withholding and related fees from the vesting. After these transactions, Troutman directly owned 62,694 common shares, with an additional 1,890 shares held indirectly through a 401(k) plan.
Zurn Elkay Water Solutions Corp President Jeffrey A. Schoon reported equity changes tied to performance-based awards and related tax obligations. On February 6, 2026, he acquired 24,981 shares of common stock for no cash consideration upon vesting of performance stock units based on a three-year performance period ending December 31, 2025.
On February 10, 2026, he sold 12,034 common shares at a weighted average price of $51.80 to cover tax withholding and related fees from the vesting. Following these transactions, he holds 62,541 common shares directly, plus 2,196 shares indirectly via a trust and 846 shares via a 401(k) plan.
Todd Adams has filed a notice of proposed sale for 5,050 shares of ZWS common stock. The shares are expected to be sold through Fidelity Brokerage Services LLC on the NYSE around 02/10/2026, with an aggregate market value of $261,601.62 and 166,797,974 shares outstanding.
The 5,050 shares were acquired on 02/09/2026 via restricted stock vesting from the issuer as compensation. Over the prior three months, Todd Adams sold 263,347 common shares for gross proceeds of $13,873,804.67, and the notice confirms he knows of no undisclosed material adverse information.
A holder of common stock filed a notice of proposed sale under Rule 144 to sell 35,267 shares through Fidelity Brokerage Services LLC on the NYSE. The filing shows an aggregate market value of $1,829,694.68 for these shares, with 166,797,974 shares outstanding at the issuer level. The shares were acquired on 02/09/2026 via restricted stock vesting as compensation, with the planned sale date listed as 02/10/2026. By signing, the seller represents they are not aware of any material adverse, non‑public information about the issuer’s current or prospective operations.